ADME Toxicology Testing Market Research Report – Global Forecast till 2027

ADME Toxicology Testing Market Research Report, by Method (Cellular Assay, Ex-vivo), Technology (Cell Culture, Biochemical Assay, Molecular Imaging), Application (Systemic, Renal), End-User (Hospital & Clinic, Diagnostic Centre)- Forecast Till 2027

ID: MRFR/LS/5480-HCR | February 2021 | Region: Global | 90 pages

ADME Toxicology Testing Market Scenario:


The ADME Toxicology Testing Market size is projected to register a CAGR of 11.4% over the forecast period. ADME Toxicology Screening System are integrated workstation that describing of the absorption, distribution, metabolism, and excretion properties of drug molecules. The system is enabled with highly integrated software that is used for sample testing. Moreover, it provides accurate toxicity test for the drug development and biopharmaceutical production. The key factor responsible for influencing this market is the rising application of ADME toxicology testing by pharmaceuticals and biotechnology companies, and growing concerns over application of animals in clinical trials have aided the growth of the toxicology testing market. However, factors such as, lack of in-vitro models to detect autoimmunity and immune-stimulation are expected to restrict the ADME Toxicology Testing Market growth during the forecast period.


Segmentation:


The ADME Toxicology Testing Market is segmented on the basis of method, technology, application, and end-user. The Market, by method is categorised into cellular assay, biochemical assay, in silica, and ex-vivo. The technology segment is categorised into cell culture, high throughput, molecular imaging, and OMICS technology. On the basis of application, the ADME Toxicology Testing Market is segmented into systemic toxicity, renal toxicity, hepatotoxicity, neurotoxicity, and others. On the basis of end-user, the market is segmented into hospitals and clinics, diagnostic centres, pathological labs, and others.


On the basis of region, the global ADME Toxicology Testing Market is segmented into the Americas, Europe, Asia-Pacific, and the Middle East and Africa. The Americas is sub-segmented into North America and South America. The North American region is further segmented into the US and Canada. The European region is divided into two, namely, Western Europe and Eastern Europe. Western Europe is further classified into Germany, Italy, France, the UK, Spain, and the rest of Western Europe. The Asia-Pacific region is sub-segmented into Japan, China, India, Australia, the Republic of Korea, and the rest of Asia-Pacific. The Middle Eastern and African region is sub-segmented into the United Arab Emirates, Saudi Arabia, Oman, Kuwait, Qatar, and the rest of the Middle East and Africa.


Regional Market Summary


It is projected that the Americas dominated the global ADME toxicology testing market owing to the growth in the North America region which is largely attributed to the factors such as increase in research funding, growing awareness on the benefits of ADME toxicology testing for commercial industries, and high adoption of toxicology testing in research. These factors have cumulatively influenced the growth of the market in this regionEurope stood second largest in the ADME toxicology testing market owing to high acceptance of toxicology testing in research. Additionally, development in research expenditure was also responsible for the development of market. Moreover, in January 2014, Cyprotex PLC, a UK based company signed an acquisition agreement with CeeTox, Inc. for its business. The company intended to expand its portfolio for in-vitro toxicity assays and screening services to the Cosmetics and Personal Care Industry.


Asia-Pacific was projected to be the fastest growing region for the global ADME toxicology testing market in 2017. The factors attributed to the due to increased efforts for development of new diagnostic devices and adoption of newer technologies to improve the standard of diagnostics assays being supplied. China and Japan are key countries contributing to market growth.The Middle East and Africa holds the least share in the global ADME toxicology testing market due to the presence of poor health expenditure and economically diverse countries. However, the market is expected to witness growth due to increasing toxicology care programs in the Middle East.


ADME toxicology testing Global Market, by Method:



  •        Cellular Assay

  •        Biochemical Assay

  •        In Silica

  •        Ex-vivo


ADME toxicology testing Global Market, by Technology:



  •        Cell Culture

  •        High Throughput

  •        Molecular Imaging

  •        OMICS Technology


ADME toxicology testing Global Market, by Application:



  •        Systemic Toxicity

  •        Renal Toxicity

  •        Hepatotoxicity

  •        Neurotoxicity

  •        Others


ADME toxicology testing Global Market, by End-Users:



  •       Hospitals and clinics

  •       Diagnostic centers

  •       Pathological Labs

  •       Others


ADME toxicology testing Global Market, by Region:



  •        Americas

  •        Europe

  •        Asia-Pacific

  •       Middle East & Africa


Global ADME toxicology testing Global Market, by Key Players:



  •        Promega Corporation

  •        Agilent Technologies, Inc.

  •        Thermo Fisher Scientific, Inc.

  •        Bio-Rad Laboratories, Inc.

  •        Beckman Coulter, Inc.

  •        Cellartis AB

  •        Cyprotex PLC.

  •        Life Technologies Corporation

  •        Optivia Biotechnology, Inc.

  •        Accelrys, Inc.

  •        Molecular Discovery Ltd.

  •        Cyprotex PLC

  •        MultiCASE, Inc.


Intended Audience:



  • Pharmaceutical companies

  • Biotechnological institutes

  • Diagnostics Laboratories

  • Pathological Institutes

  • Government and private laboratories

  • Research and Development (R&D) companies

  • Medical research laboratories

  • Market research and consulting service providers



Report Scope:
Report Attribute/Metric Details
  Market Size

  • 2027: Significant Value
  • 2017:USD 1,050 Mn
  •   CAGR   2018-2023: ~11.4%
      Base Year   2019
      Forecast Period   2027
      Historical Data   2018
      Forecast Units   Value (USD Million)
      Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
      Segments Covered   Method, Technology, Application, and End-user
      Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
      Key Vendors   Promega Corporation, Agilent Technologies, Inc., Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, Inc., Beckman Coulter, Inc., Cellartis AB, Cyprotex PLC., Life Technologies Corporation, Optivia Biotechnology, Inc., Accelrys, Inc., Molecular Discovery Ltd., Cyprotex PLC, MultiCASE, Inc., Caliper Life Sciences, Inc., Xceleron, Inc., ACEA Biosciences, Inc., Albany Molecular Research, Inc., CeeTox, Inc., and others.
      Key Market Opportunities

  • Increase in research funding
  • Growing awareness on the benefits of ADME toxicology testing for commercial industries
  • High adoption of toxicology testing in research
  •   Key Market Drivers

  • Rising application of ADME toxicology testing by pharmaceuticals and biotechnology companies
  • Growing concerns over application of animals in clinical trials


  • Speak to Analyst Ask for Customization

    Frequently Asked Questions (FAQ) :


    The ADME Toxicology Testing Market is expected to register a CAGR of 11.4% during forecast period upto 2023.

    The Growing concerns over application of animals in clinical trials is the major driving factor of ADME Toxicology Testing Market.

    Promega Corporation, Agilent Technologies, Inc., Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, Inc., Beckman Coulter, Inc., Cellartis AB, Cyprotex PLC., Life Technologies Corporation, Optivia Biotechnology, Inc., Accelrys, Inc., Molecular Discovery Ltd., Cyprotex PLC, MultiCASE, Inc., Caliper Life Sciences, Inc., Xceleron, Inc., ACEA Biosciences, Inc., Albany Molecular Research, Inc., CeeTox, Inc., and others.